|
시장보고서
상품코드
2058372
당화 알부민 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별Glycated Albumin Market, By Product Type, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
당화 알부민 시장은 2026년에 1억 3,390만 달러로 추정되며, 2033년까지 2억 3,460만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 8.5%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 1억 3,390만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 8.50% | 2033년 시장 규모 예측: | 2억 3,460만 달러 |
당화 알부민이란 포도당과 결합한 알부민을 말합니다. 알부민은 혈액과 체액, 장기에 존재하며, 세포의 형태를 유지하는 기능을 하고, 체내의 호르몬, 영양소, 일부 약물의 운반을 돕는 역할을 합니다. 당화 알부민은 당뇨병의 진단 및 관리에 있어 새로운 바이오마커로 주목받고 있습니다. 또한, 지난 수십 년간 당뇨병의 혈당 모니터링 분야에서도 그 중요성이 커지고 있습니다.
시장 역학
시장의 주요 기업들이 신규 당화 알부민 제품을 잇달아 승인함에 따라, 가까운 시일 내에 전 세계 당화 알부민 키트/분석 시장이 성장할 것으로 예상됩니다. 예를 들어, 2017년에는 미국 식품의약국(FDA)이 일본의 아사히카세이 파마 주식회사에 대해 당화 알부민(GA-L)용 체외진단용 어세이 키트인 신제품 'Lucica Glycated Albumin-L'에 대해 510(k) 승인을 부여했습니다.
또한, 당뇨병 유병률의 증가에 따라 제1형 및 제2형 등 다양한 유형의 당뇨병 진단 및 검출에 사용될 수 있는 당화 알부민 제품에 대한 수요가 증가할 것으로 예상됩니다. 예를 들어, 미국당뇨병학회가 2015년에 발표한 자료에 따르면, 당뇨병은 미국에서 7번째로 많은 사망 원인이자, 미국 내 약 3,030만 명이 당뇨병을 앓고 있습니다. 그중 20세 미만의 미국인 약 19만 3,000명이 당뇨병을 앓고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 당화 알부민 시장의 주요 기업 개요을 작성하였습니다. 구체적으로는 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 발전 및 전략, 그리고 향후 계획입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 해당 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 당화 알부민 시장 분석에 활용된 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 당화 알부민 시장 : 제품 유형별, 2021-2033년
제5장 세계의 당화 알부민 시장 : 용도별, 2021-2033년
제6장 세계의 당화 알부민 시장 : 최종사용자별, 2021-2033년
제7장 세계의 당화 알부민 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.06.19Glycated Albumin Market is estimated to be valued at USD 133.9 Mn in 2026 and is expected to reach USD 234.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 133.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.50% | 2033 Value Projection: | USD 234.6 Mn |
Glycated albumin refers to albumin that are bonded to glucose. Albumin is present in blood and body fluids organs, and functions to maintain the shape of cell and helps in the distribution of hormones, nutrients, and some drugs in the body. Glycated albumin has been described as novel biomarkers for the detection and management of diabetes. It has also gained importance in glycemic monitoring for diabetes mellitus over the past few decades.
Market Dynamics
Increasing approval of novel glycated albumin products by key players in the market is expected to drive global glycated albumin kits/assays market growth in the near future. For instance, in 2017, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Japan-based Asahi Kasei Pharma Corporation for its new Lucica Glycated Albumin-L, an in vitro diagnostic assay kit for glycated albumin (GA-L).
Furthermore, increasing prevalence of diabetes is expected to increase the demand for glycated albumin products, which can be used for the diagnosis/ detection of different types of diabetes such as type 1, and type 2 diabetes. For instance, according to the data published by the American Diabetes Associations in 2015, diabetes is the 7th leading cause of death in the U.S., where around 30.3 million people in the U.S. are suffering from diabetes. Among these, around 193,000 people in the U.S. below the age of 20 are suffering from diabetes.
Key features of the study
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global glycated albumin market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
- Key companies covered as a part of this study include Lifespan Biosciences, Biomatik Corporation, Abbexa Ltd., G Biosciences, DRG International, Inc., Amsbio LLC, Signalway Antibody LLC, United States Biological, Diazyme Laboratories, Abnova Corporation, Maccura Biotechnology Co. Ltd., Exocell Inc., Biorbyt Ltd., and Epinex Diagnostics Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global glycated albumin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the glycated albumin market
Market Segmentation
- By Product Type (Revenue, USD Mn, 2021-2033)
- Human Glycated Albumin
- Animal Glycated Albumin
- By Application (Revenue, USD Mn, 2021-2033)
- Diagnosis
- Prediabetes
- Type 1 Diabetes
- Type 2 Diabetes
- Research
- By End User (Revenue, USD Mn, 2021-2033)
- Hospitals/Clinics
- Diagnostic Centers
- Research Institutes
- Others
- By Region (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Lifespan Biosciences
- Biomatik Corporation
- Abbexa Ltd.
- G Biosciences
- DRG International, Inc.
- Amsbio LLC
- Signalway Antibody LLC
- United States Biological
- Diazyme Laboratories,
- Abnova Corporation
- Maccura Biotechnology Co. Ltd.
- Exocell Inc.
- Biorbyt Ltd.
- Epinex Diagnostics Inc.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Product Launch
- Importance of Glycated Albumin
- Regulatory Scenario
- PEST Analysis
- Porter's Five Forces Analysis
4. Global Glycated Albumin Market, By Product Type, 2021 - 2033 (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Human Glycated Albumin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
- Animal Glycated Albumin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
5. Global Glycated Albumin Market, By Application, 2021 - 2033 (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Segment Trends
- Prediabetes
- Type 1 Diabetes
- Type 2 Diabetes
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
6. Global Glycated Albumin Market, By End User, 2021 - 2033 (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals/Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
7. Global Glycated Albumin Market, By Region, 2021 - 2033 (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- North America
- Market Size and Forecast, By Product Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of APAC
- Latin America
- Market Size and Forecast, By Product Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Product Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- Central Africa
- South Africa
- North Africa
- Middle East
- Market Size and Forecast, By Product Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
8. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Epinex Diagnostics Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lifespan Biosciences
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biomatik Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbexa Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- G Biosciences
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- DRG International, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amsbio LLC
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Signalway Antibody LLC
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- United States Biological
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Diazyme Laboratories
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abnova Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Maccura Biotechnology Co. Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Exocell Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biorbyt Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Epinex Diagnostics Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Epinex Diagnostics Inc.
9. Section
- References
- Research Methodology
- About us and Sales Contact
02-2025-2992
(주말 및 공휴일 제외)
(주말 및 공휴일 제외)
※ 부가세 별도
검색
